NCT03420963 2026-03-03Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid TumorsM.D. Anderson Cancer CenterPhase 1 Terminated12 enrolled
NCT04354064 2026-02-20Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid TumorsWashington University School of MedicineRecruiting100 enrolled
NCT04459273 2026-02-05FAPI PET RDRCJonsson Comprehensive Cancer CenterPhase 1 Active not recruiting26 enrolled
NCT05544929 2026-01-06A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced CancersNovartisPhase 1 Active not recruiting126 enrolled